PMV Pharmaceuticals completes venture financing

On Feb. 22, cancer company PMV Pharmaceuticals Inc. (Cranbury, N.J.) raised $74 million in a series B round led by Topspin Biotech Fund and a group of investors with Euclidean Capital. Existing inves...